A Review of Behavioral Economic Manipulations Affecting Drug versus Nondrug Choice in Rats
Rat drug choice usually follows price and income rules, but the exceptions show you need extra tools for tough cases.
01Research in Context
What this study did
Kearns (2025) read every rat study that pitted drug versus food. He grouped the results by price, income, and reinforcer type. The goal was to see if simple economic rules explain why rats choose drugs.
The paper is a narrative review, not a new experiment. It pulls together decades of lever-press data to spot patterns and gaps.
What they found
Most of the time, rats act like tiny shoppers. When the price of a drug lever goes up, they buy less of it. When food becomes cheaper, they switch to food. These results fit textbook demand curves.
Yet the review flags clear exceptions. Some rats keep pressing for ethanol even when the cost skyrockets. Others stop pressing for cocaine after one small change in delay. These outliers tell us the basic model needs extras, such as delay discounting or reinforcer interactions.
How this fits with other research
Davison et al. (1995) already showed ethanol demand is stubborn. Their rats defended ethanol intake despite climbing response requirements. Kearns uses this paper as Exhibit A for inelastic drug demand.
Higgins et al. (1992) found that fewer daily trials (‘lower income’) make rats wait longer for the bigger reward. Kearns folds this income effect into the review to explain why session length can swing drug choice.
Nickerson et al. (2015) seems to disagree. They showed delay training cut impulsive choice but did not change alcohol intake. Kearns resolves the clash: delay exposure tweaks decision style, not economic value, so demand curves stay put.
Friman (2014) argued we must spell out the behavioral mechanism of drug action. Kearns answers by listing price, income, and reinforcer type as the measurable pieces of that mechanism.
Why it matters
If you run preference assessments or token economies, treat reinforcers like goods in a mini-market. Raise the ‘price’ (effort, tokens, time) of problem behavior and lower the price of healthy alternatives. Watch for clients who keep choosing the ‘drug-like’ option despite high cost; they may need added delay training, richer competing items, or both. Use these economic levers first before layering on pharmacological fixes.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →Boost the response cost for the problem reinforcer by two tokens and cut the cost for the replacement reinforcer by one token; track which option the client picks across ten trials.
02At a glance
03Original abstract
Many recent studies have investigated rats’ choice between drug and nondrug reinforcers to model variables influencing drug taking in humans. As research using this model accumulates, the complexity of factors affecting drug choice has become increasingly apparent. This review applies a behavioral economic perspective to research that has used this model. The focus is on experiments that have manipulated behavioral economic variables in studies of rats’ choice between drugs like cocaine or heroin and nondrug reinforcers like saccharin or social interaction. Price effects, reinforcer interactions (i.e., as substitutes or complements), economy type, and income effects are described. Results of experiments testing the impact of these variables on rats’ choice are presented and analyzed. Although rats’ behavior in this model often conforms well with behavioral economic principles, there have also been instances where further explanation is required. By appreciating the behavioral economic context in which rats’ choice between drug and nondrug reinforcers occurs, and by recognizing that both consequences and antecedents can play important roles in this behavior, our understanding of the complexity of factors involved in drug choice can be increased.
Perspectives on Behavior Science, 2025 · doi:10.1007/s40614-025-00445-5